-+ 0.00%
-+ 0.00%
-+ 0.00%

AcuCort Files New Drug Application for Zeqmelit in US

MT Newswires·11/16/2026 05:23:19
Listen to the news
05:23 AM EST, 11/16/2026 (MT Newswires) -- AcuCort (ACUC.ST) filed its new drug application to secure Zeqmelit's marketing authorization in the US, according to a Monday release. The application expects to receive the US Food and Drug Administration's approval in the second half of 2027. The pharmaceutical group added that it plans to commercially launch Zeqmelit in the first half of 2028.